Fundraising FoxBold Capital Partners — 2019 Investments
4 investments dated 2019 · listed companies and verified rows first · show all
Exo is a company backed by leading venture capital and corporate investors focused on innovative technologies, with particular emphasis on healthcare, bioelectronic medicines, materials science, and deep technology solutions.
AI & Machine LearningBiotechDeep TechHealthtechMedical Devices
Yusuf Haque(Founder)in
Co-investorsCreative VenturesPage One VenturesTDK VenturesIntel CapitalOSF VenturesSquareOne Capital+6 more
.jpeg){kind=logo}
ParkourSC (formerly Cloudleaf) offers an AI-based "Decision Intelligence" platform for managing and solving complex supply chain challenges for global businesses.
AI & Machine LearningEnterprise SoftwareLogistics & Supply ChainSaaSMilpitas, US
Mahesh Veerina(Chief Executive Officer and President)inNeal Bhadkamkar(Director)inScott Gorton(Executive Officer)
BoardSriram Viswanathan(Director)inSudhir Rao(Director)in
Co-investorsTandem CapitalWestern Technology InvestmentBluePointe VenturesCelesta CapitalIntel Capital
Deciduous Therapeutics develops small molecule and immunomodulatory therapies targeting senescent cells to treat age-related diseases including Type 1 diabetes, autoimmunity, and metabolic disorders.
BiotechDigital HealthLongevitySan Francisco, US
Robin Mansukhani(CEO and Co-Founder)inAnil Bhushan(Scientific Founder)in
BoardDylan Morris(Director)in
Co-investorsage1Cornucopian Capital ManagementCRV (Charles River Ventures)GaingelsLifespan Vision VenturesLong Game+4 more
__Twitter.png)
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Crowdz
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.